Cangene Antidote for Bioterror Toxin Wins Advisers’ Support

Cangene Corp.’s experimental antidote for a toxin considered a bioterrorism threat won the support of U.S. regulatory advisers.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.